Rutin: Therapeutic potential and recent advances in drug delivery

Expert Opinion on Investigational Drugs

Volumn 22, Issue 8, 2013, Pages 1063-1079

  Sharma, Shrestha ^a   Ali, Asgar ^a   Ali, Javed ^a   Sahni, Jasjeet K ^a   Baboota, Sanjula ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Antioxidant; Bioavailability; Bioflavonoids; Rutin

Indexed keywords

AMPICILLIN; GLYCYRRHETINIC ACID PHOSPHOLIPID COMPLEX; LEVOFLOXACIN; OFLOXACIN; PIROXICAM BETA CYCLODEXTRIN; QUERCETIN; RUTOSIDE;

ANTIBACTERIAL ACTIVITY; ANTICOAGULATION; ANTIDIABETIC ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIHYPERTENSIVE ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; AREA UNDER THE CURVE; ARTICLE; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEART INFARCTION; HEART PROTECTION; HUMAN; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PARKINSONISM; TIME TO MAXIMUM PLASMA CONCENTRATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIHYPERTENSIVE AGENTS; ANTIOXIDANTS; BIOLOGICAL AVAILABILITY; DRUG DELIVERY SYSTEMS; HUMANS; HYPOGLYCEMIC AGENTS; HYPOLIPIDEMIC AGENTS; RUTIN; SOLUBILITY;

EID: 84880241949     PISSN: 13543784     EISSN: 17447658     Source Type: Journal    
DOI: 10.1517/13543784.2013.805744     Document Type: Article

References (109)

1. Nijveldt RJ, van Nood E, van Hoorn DEC, et al. Flavonoids: A review of probable mechanisms of action and potential applications. Am J Clin Nutr 2001;74:418-25
2. Narayana KR, Reddy MS, Chaluvadi MR, et al. Bioflavonoids classification, pharmacological, biochemical effects and therapeutic potential. Ind J Pharmcol 2001;33:2-16
3. Williams RJ, Spencer JPE, Rice-Evans C. Flavonoids: Antioxidants or signalling molecules? Free Radic Biol Med 2004;36:838-49
4. Petkov E, Nickdor N, Uzunov P. Inhibitory effects of flavonoids on xanthine oxidase. Planta Med 1981;43:183-7
5. González-Gallego J, Sánchez-Campos S, Tunön MJ. Anti-inflammatory properties of dietary flavonoids. Nutr Hosp 2007;22:287-93
6. Garcia-Mediavilla V, Crespo I, Collado PS, et al. The anti-inflammatory flavones quercetin and kaempferol cause inhibition of inducible nitric oxide synthase, cyclooxygenase-2 and reactive C-protein, and down-regulation of the nuclear factor kappa B pathway in Chang Liver cells. Eur J Pharmacol 2007;557:221-9
7. Hertog MGL, Hollman PCH, Katan MB, et al. Intake of potentially anticarcinogenic flavonoids and their determinants in adults in the Netherlands. Nutr Cancer 1993;20:21-9
8. Hirano T, Oka K, Akiba M. Antiproliferative effects of synthetic and naturally occurring flavonoids on turner cells of the human breast carcinoma cell line, 2R- 75-1. Res Commun Chem Pahol Pharmacol 1989;64:69-78
9. Catherine C, Malc S, Esther HL, et al. Lack of tumour-Promoting effects of flavonoids: Studies on rat liver preneostatic foci and on in vivo and in vitro gap junctional inter cellular communication. Nutr Cancer 1996;26:251-63
10. Gabor M, Eperjessy E. Antimicrobial activity of flavonoids from leaves of chinese herb. Nature 1966;212:1273-9
11. Tereschuk ML, Riera MVQ, Casteo GR, et al. Antimicrobial activity of flavonoids from leaves of Tagetes minuta. J Ethnopharmacol 1997;56:227-36
12. Mahmood N, Pizza C, Aquino R, et al. Inhibition of HIV infection by flavonoids. Antiviral Res 1993;22:189-97
13. Tripathi VD, Rastogi RP. In vitro anti-HIV activity of flavonoids isolated from Garcinia multifolia. J Sci Indian Res 1981;40:116-21
14. Kais N, Rahman MM, Rashid MA, et al. Effect of flavonoid compounds on the immune system. Fitoterapia 1996;67:554-61
15. Middleton E Jr. Effect of plant flavonoids on immune and inflammatory cell function. Adv Exp Med Bio 1998;439:175-82
16. Hirasawa T, Shoji T, Hoshino E, et al. Clinical study of effect of SU-88 on gastric ulcer combination of treatment. Japan Pharmacol Ther 1982;10:5
17. Gomi K, Kwayama H, Abe M, et al. Clinical evaluation of SU-88 on pepticulcer. Japan Pharmacol Ther 1982;10:1
18. Bombardelli E, Morazzoni P. The flavonoids: New perspectives in biological activities and therapeutics. Chim Oggi 1993;11:25-8
19. Calabro ML, Tommasini S, Donato P, et al. The rutin/beta-cyclodextrin interactions in fully aqueous solution: Spectroscopic studies and biological assays. J Pharm Biomed Anal 2005;36:1019-27
20. Mauludin R, Müller RH, Keck CM. Development of an oral rutin nanocrystal formulation. Int J Pharm 2009;370:202-9
21. Chen S, Gong J, Liu F, et al. Naturally occurring polyphenolic antioxidants modulate IgE-mediated mast cell activation. Immunology 2000;100:471-80
22. Ihme N, Kiesewetter H, Jung F, et al. Leg oedema protection from a buckwheat herb tea in patients with chronic venous insufficiency: A single-centre, randomised, double-blind, placebo-controlled clinical trial. Eur J Clin Pharmacol 1996;50:443-7
23. Deschner EE, Ruperto J, Wong G, et al. Quercetin and rutin as inhibitors of azoxymethanol-induced colonic neoplasia. Carcinogenesis 1991;12:1193-6
24. Panasiak W, Wleklik M, Oraczewska A, et al. Influence of flavonoids on combined experimental infections with EMC virus and Staphylococcus aureus in mice. Acta Microbiol Pol 1989;38:185-8
25. Park SY, Bok SH, Jeon SM, et al. Effect of rutin and tannic acid supplements on cholesterol metabolism in rats. Nutr Res 2002;22:283-95
26. Webster RP, Gawde MD, Bhattacharya RK. Protective effect of rutin, a flavonol glycoside, on the carcinogen-induced DNA damage and repair enzymes in rats. Cancer Lett 1996;109:185-91
27. Ahmed OM, Moneim AA, Yazid A, et al. Mahmoud AM. Antihyperglycemic, antihyperlipidemic and antioxidant effects and the probable mechanisms of action of ruta graveolens infusion and rutin in nicotinamide-Streptozotocin-induced diabetic rats. Diabetologia Croatica 2010;39:15-35
28. Hodnick WF, Kung FS, Roettger WJ, et al. Inhibition of mitochondrial respiration and production of toxic oxygen radicals by flavonoids. A structure-activity study. Biochem Pharmacol 1986;35:2345-57
29. Miyake K, Arima H, Hirayama F, et al. Improvement of solubility and oral bioavailability of rutin by complexation with 2-hydroxypropyl-beta- cyclodextrin. Pharm Dev Technol 2000;5:399-407
30. Esquenazi D, Wigg MD, Miranda MFS, et al. Antimicrobial and antiviral activities of polyphenolics from Cocos nucifera Linn. (Palmae) husk fiber extract. Res Microbio 2002;153:647-52
31. Tim Cushnie TP, Lamb AJ. Antimicrobial activity of flavonoids. Int J Antimicro Agents 2005;26:343-56
32. Orhan DD, Ozcelik B, Ozgen S, et al. Antibacterial, antifungal, and antiviral activities of some flavonoids. Microbio Res 2010;165:496-504
33. Johann S, Mendes BG, Missau FC, et al. Antifungal activity of five species of polygala Brazilian. J Microbial 2011;42:1065-75
34. Arima H, Ashida H, Danno GI. Rutin enhanced antibacterial activities of flavonoids against Bacillus cereus and Salmonella enteriditis. Biosci Biotechnol Biochem 2002;66:1009-14
35. Swanson H, Hughes PA, Messer SA, et al. Candida albicans arthritis one year after successful treatment of fungemia in a healthy infant. J Pediatr 1996;129:688-94
36. Calvo-Romero JM, Alvarez-Vega JL, Salazar-Vallinas JM, et al. Candida arthritis in an immunocompetent patient without predisposing factors. Clin Rheumatol 1998;17:393-4
37. Arnold HJ, Dini A, Jonas G, et al. Candida albicans arthritis in a healthy adult. South Med J 1981;74:84-5
38. Yongmoon H. Rutin has therapeutic effect on septic arthritis caused by Candida albicans. Int Immunopharmacol 2009;9:207-11
39. Chen SS, Gong J, Liu FT, et al. Naturally occurring polyphenolic antioxidants modulate IgE-mediated mast cell activation. Immunology 2000;100:471-80
40. Pandey KB, Rizvi SI. Plant polyphenols as dietary antioxidants in human health and disease. Oxid Med Cell Longev 2009;2:270-8
41. Benavente-Garia O, Castillo J, Marin FR, et al. Use and properties of citrus flavonoids. J Agri Food Chem 1997;45:4505-15
42. Bombardelli E, Morazzoni P. The flavonoids: New perspectives in biological activities and therapeutics. Chim Oggi 1993;11:25-8
43. Yang J, Guo J, Yuan J. In vitro antioxidant properties of rutin. LWT 2008;41:1060-6
44. Kamalakkannan N, Stanely- Mainzen Prince P. Rutin improves the antioxidant status in streptozotocin-induced diabetic rat tissues. Mol Cell Biochem 2006;293:211-19
45. Bhandary B, Piao CS, Kim DS, et al. The protective effect of rutin against Ischemia/reperfusion-associated Hemodynamic alteration through antioxidant activity. Arch Pharm Res 2012;35:1091-7
46. Ramos S. Cancer chemoprevention and chemotherapy: Dietary polyphenols and signaling pathways. Mol Nutr Food Res 2008;52:507-26
47. Jemal A, Siegel R, Ward E, et al. Cancer statistics. J Clin 2008;58:71-96
48. Soobrattee MA, Bahorun T, Aruoma OI. Chemopreventive actions of polyphenolic compounds in cancer. Biofactors 2006;27:19-35
49. Matsukawa Y, Nishino H, Okuyama Y, et al. Effects of quercetin and/or restraint stress on formation of aberrant crypt foci induced by azoxymethane in rat colons. Oncology 1997;54:118-21
50. Gong G, Qin Y, Huang W, et al. Rutin inhibits hydrogen peroxide-induced apoptosis through regulating reactive oxygen species mediated mitochondrial dysfunction pathway in human umbilical vein endothelial cells. Eur J Pharmacol 2009;628:27-35
51. Yang JS, Jing-Pin L, Jen-Jyh L, et al. Rutin inhibits human leukemia tumor growth in a murine xenograft model in vivo. Inc Environ Toxicol 2011;27:480-4
52. Ali H, Dixit S. Anticancer effect of rutin isolated from the methanolic extract of Triticum aestivum straw in mice. HOPE 2012;7:1-14
53. Ara-ujo JR, Gonçalves P, Martel F. Chemopreventive effect of dietary polyphenols in colorectal cancer cell lines. Nut Res 2011;31:77-87
54. Deschner EE, Ruperto J, Wong G, et al. Quercetin and rutin as inhibitors of azoxymethanol-induced colonic neoplasia. Carcinogenesis 1991;12:1193-6
55. You KM, Jong HG, Kim HP. Inhibition of cyclooxygenase/lipoxygenase from human platelets by polyhydroxylated/methoxylated flavonoids isolated from medicinal plants. Arch Pharm Res 1999;22:18-24
56. Vlahos CJ. Phosphatidylinositol 3-kinase inhibitors and their effects on cell signaling pathways. Drugs Future 1995;20:165-71
57. Lindahl M, Tagesson C. Flavonoids as phospholipase A2 inhibitors: Importance of their structure for selective inhibition of group II phospholipase A2. Inflammation 1997;21:347-56
58. Laid S, Hamama B, Chafia T, et al. Anti-inflammatory effect of rutin on rat paw oedema, and on neutrophils chemotaxis and degranulation. Exp Toxic Pathol 2003;54:313-18
59. Lee W, Ku SK, Bae JS. Barrier protective effects of rutin in LPS-induced inflammation in vitro and in vivo. Food Chem Tox 2012;50:3048-55
60. Arjumand W, Seth A, Sultana S. Rutin attenuates cisplatin induced renal inflammation and apoptosis by reducing NFkB, TNF-a and caspase-3 expression in wistar rats. Food Chem Toxi 2011;49:2013-21
61. Xia ML, Zhou XM, Yao H, et al. Rutin-induced endothelium-dependent vasorelaxation in rat aortic Rings and the underlying mechanism. Conf Proc IEEE Eng Med Biol Soc 2005;6:5595-7
62. Lapa FR, Soares KC, Rattmann YD, et al. Vasorelaxant and hypotensive effects of the extract and the isolated flavonoid rutin obtained from polygala paniculata L. J Pharm Pharmacol 2011;63:875-81
63. Guerrero L, Castillo J, Quinones M, et al. Inhibition of angiotensin-converting enzyme activity by flavonoids: Structure-activity relationship studies. Plos One 2012;7:1-11
64. Sattanathan K, Dhanapal CK, Manavalan R. Antihypertensive and other beneficial health effects of rutin supplementation in diabetic patients. Res J Pharm Bio Chem Sci 2011;2:843-9
65. Vajreswari W, Narayanareddy K. Effect of dietary fats on some membrane bound enzyme activities, membrane lipid composition and fatty acid profiles of rat heart sarcolemma. Lipids 1992;27:339-43
66. Stanely P, Prince M, Karthick M. Preventive effect of rutin on lipids, lipoproteins, and ATPases in normal and isoproterenol-induced myocardial infarction in rats. J Biochem Mol Toxicol 2007;21:1-6
67. Punithavathi VR, Shanmugapriya K, Stanely -Mainzen PP. Protective effects of rutin on mitochondrial damage in isoproterenol-induced cardiotoxic rats: An in vivo and in vitro study. Cardiovasc Toxicol 2010;10:181-9
68. Sattanathan K, Dhanapal CK, Manavalan R. LDL lowering properties of rutin in diabetic patients. Int J Pharm Bio Sci 2010;4:467-73
69. Hii CST, Howell SL. Effects of flavonoids on insulin secretion and Ca +2 handling in rat islets of Langerhans. J Endocrinol 1985;107:1-8
70. Lee MK, Park YB, Kang MA, et al. Effect of citrus flavonoids on lipid metabolism and glucose-regulating enzyme mRNA levels in type-2 diabetic mice. Int J Biochem Cell Biol 2006;38:1134-45
71. Anandharajan R, Pathmanathan K, Shankernarayanan NP, et al. Upregulation of GLUT-4 and PPARg by an isoflavone from Pterocarpus marsupium on L6 myotubes: A possible mechanism of action. J Ethnopharmacol 2005;97:253-60
72. Ahmed OM, Moneim AA, Yazid IA, et al. Antihyperglycemic, antihyperlipidemic and antioxidant effects and the probable mechanisms of action of ruta graveolens infusion and rutin in nicotinamidestreptozotocin-induced diabetic rat. Diabetol Croat 2010;39:15-35
73. Kamalakkannan N, Stanely-Mainzen PP. Antihyperglycaemic and antioxidant effect of rutin, a polyphenolic flavonoid, in streptozotocin-induced diabetic wistar rats. Basic Clin Pharmacol Toxicol 2006;98:97-103
74. Ricart E, Panaccione R, Loftus EV, et al. Autoimmune disorders and extra intestinal manifestations in first-degree familial and sporadic inflammatory bowel disease: A case-control study. Inflamm Bowel Dis 2004;10:207-14
75. Muraoka K, Shimizu K, Sun X, et al. Flavonoids exert diverse inhibitory effects on the activation of NF-kappaB. Transplant Proc 2002;34:1335-40
76. Rabiskova M, Bautzova T, Gajdziok J, et al. Coated chitosan pellets containing rutin intended for the treatment of inflammatory bowel disease: In vitro characteristics and in vivo evaluation. Int J Pharm 2012;422:151-9
77. Kim H, Kong H, Choi B, et al. Metabolic and pharmacological properties of rutin, a dietary quercetin glycoside, for treatment of inflammatory bowel disease. Pharm Res 2005;22:1499-509
78. Gao HM, Kotzbauer PT, Uryu K, et al. Neuroinflammation and oxidation/nitration of alpha synuclein linked to dopaminergic neurodegeneration. J Neurosci 2008;28:7687-98
79. Khan MM, Ahmad A, Ishrat T, et al. Rutin protects the neural damage induced by transient focal ischemia in rats. Brain Res 2009;1292:123-35
80. Moshahid KM, Raza SS, Javed H, et al. Rutin Protects Dopaminergic Neurons from Oxidative Stress in an Animal Model of Parkinson's Disease. Neurotox Res 2012;22:1-15
81. Rodrigues AMG, Marcilio F, Muzitano M, et al. Therapeutic potential of treatment with the flavonoid rutin after cortical focal ischemia in rats. Brain Res 2013;1503:53-61
82. Bishnoi M, Chopra K, Kulkarni SK. Protective effect of rutin, a polyphenolic flavonoid against haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes. Fundam Clin Pharmacol 2007;21:521-9
83. Richetti SK, Blank M, Capiotti KM, et al. Quercetin and rutin prevent scopolamine-induced memory impairment in zebrafish. Behav Brain Res 2011;217:10-15
84. Javed H, Khan MM, Ahmad A, et al. Rutin prevents cognitive impairments by ameliorating oxidative stress and neuroinflammation in rat model of sporadic dementia of Alzheimer type. Neuroscience 2012;210:340-52
85. Almeida JS, Benvegn-u DM, Boufleur N, et al. Hydrogels containing rutin intended for cutaneous administration: Efficacy in wound healing in rats. Drug Dev Indus Pharm 2012;38:792-9
86. Tran NQ, Joung YK, Lih E, et al. In situ forming and rutin-releasing chitosan hydrogels as injectable dressings for dermal wound healing. Biomacromolecules 2011;12:2872-80
87. Boyle SP, Dobson VL, Duthie SJ, et al. Bioavailability and efficiency of rutin as an antioxidant: A human supplementation study. Eur J Clin Nut 2000;54:774-84
88. Hendler SS, Rorvik D. PDR for nutritional supplements. 2nd edition. Thomson Healthcare; Montvale (NJ): 2008
89. Yang C, Hsiu S, Wen K, et al. Bioavailability and metabolic pharmacokinetics of rutin and quercetin in rats. J Food Drug Ana 2005;13:244-50
90. Manach C, Williamson G, Morand C, et al. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 2005;81:230S-42S
91. Xiao L, Daoquan T, Xiaoxing Y, et al. Pharmacokinetic study of rutin in normal and diabetic nephropathy rats. Acta Acad Med Xuzhou 2009;11:708-12
92. Boyle SP, Dobson VL, Duthie SJ, et al. Bioavailability and efficiency of rutin as an antioxidant: A human supplementation study. Eur J Clin Nutr 2000;54:774-82
93. Erlund I, Kosonen T, Alfthan G, et al. Pharmacokinetic of quercetin from quercetin aglycone and rutin in healthy volunteers. Eur J Clin Pharmacol 2000;56:545-53
94. Chen I, Tsai Y, Huang C, et al. Lymphatic absorption of quercetin and rutin in rat and their pharmacokinetics in systemic plasma. J. Agric Food Chem 2010;58:546-51
95. Lauro MR, Torre M.L, Maggi L, et al. Fast- and slow-release tablets for oral administration of Flavonoids: Rutin and Quercetin. Drug Dev Ind Pharm 2002;28:371-9
96. Loftsson T, Brewster ME. Pharmaceutical applications of cyclodextrins. Drug solubilization and stabilization. J Pharm Sci 1996;85:1017-24
97. Lin HS, Chean CS, Nug YY, et al. 2-Hydroxypropyl- 13 b-cyclodextrin increases aqueous solubility and photostability of all-trans-retinoic acid. J Clin Pharm Ther 2000;25:265-9
98. Sri KV, Kondaiah A, Ratna JV, et al. Preparation and characterization of quercetin and rutin cyclodextrin inclusion complexes. Drug Dev Ind Pharm 2007;33:245-53
99. Nguyen T, Liu B, Zhao J, et al. An investigation into the supramolecular structure, solubility, stability and antioxidant activity of rutin/cyclodextrin inclusion complex. Food Chem 2013;136:186-92
100. Kidd PM, Head K. A review of the bioavailability and clinical efficacy of milk thistle phytosome: A silybin-phosphatidylcholine complex (Siliphos-). Altern Med Rev 2005;10:193-203
101. Bombardelli E, Curri SB, Loggia RD, et al. Complex between phospholipids and vegetal derivatives of biological interest. Fitoterapia 1989;60:1-9
102. Jain S, Dhanotiya C, Malviya N. Physicochemical characterization and determination of free radical scavenging activity of rutin-phospholipid complex. Int J Pharm Sci Res 2012;3:909-13
103. Singh D, Rawat MS, Semalty A, et al. Rutin-phospholipid complex: An innovative technique in novel drug delivery system-NDDS. Curr Drug Deliv 2012;9:305-14
104. Kumar A, Ahuja A, Ali J, et al. Conundrum and therapeutic potential of curcumin in drug delivery. Critical Rev Thera Drug Carr Sys 2010;27:279-320
105. Mauludin R, Müller RH, Keck CM. Development of an oral rutin nanocrystal formulation. Int J Pharm 2009;370:202-9
106. Almeida JS, Lima F, Ros S, et al. Nanostructured systems containing rutin: In vitro antioxidant activity and photostability studies. Nanoscale Res Lett 2010;5:1603-10
107. Kumar VP, Khan A. Formulation design and evalution of rutin loaded selfemulsifying drug delivery system (SEDDs) using edible oil. Asia J Pharm Clin Re 2012;5:76-8
108. Banjare L, Ghillare N. Development of biocompatible nanoparticles for sustained topical delivery of Rutin. Int J Pharm Bio Arch 2012;3:326-32
109. Kamel R, Basha M, Abd El-Alim SH. Development of a novel vesicular system using a binary mixture of sorbitan monostearate and polyethylene glycol fatty acid esters for rectal delivery of rutin. Liposome Res 2013;23:28-36